EFG Asset Management Americas Corp. Has $4.44 Million Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY

AI Briefing

• – EFG Asset Management Americas Corp. lowered its holdings in Alnylam Pharmaceuticals by 16.2%.
• – The institutional investor owned 9,738 shares of the biopharmaceutical company’s stock after selling 1,877 shares during the quarter.
• – EFG sold 1,877 shares of Alnylam Pharmaceuticals during the third quarter.